| 产品名称 | ReVacc Scientific M85H4 | VSV-Pseudovirus Lassa Virus Glycoprotein Complex with Luciferase Reporter (Josiah Strain) |
|---|---|
| 目录号 | M85H4 |
| 别名 | VSV-Pseudovirus Lassa Virus Glycoprotein Complex with Luciferase Reporter (Josiah Strain) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| M85H4 | 200 μl; 1000 μl | 咨询 | 咨询 |
ReVacc Scientific M85H4 | VSV-Pseudovirus Lassa Virus Glycoprotein Complex with Luciferase Reporter (Josiah Strain)
品名:VSV-Pseudovirus Lassa Virus Glycoprotein Complex with Luciferase Reporter (Josiah Strain)
货号:M85H4
品牌:ReVacc Scientific
规格:200 μl; 1000 μl
产品描述
Organism:Lassa virus (LASV), virus caused Lassa fever.
This pseudotyped virus uses recombinant vesicular stomatitis virus (rVSV) to carry glycoprotein complex (GPC) of Lassa virus (LASV) Josiah Strain (GenBank: P08669). LASV causes Lassa fever that is a severe hemorrhagic manifestations. GPC including GP1, GP2 and an unusual stable signal peptide (SSP) is responsible for receptor binding and fusion of the virion with a cell membrane. As pseudovirus infectivity of rVSV without its original G is restricted to a single round of replication, the pseudotypes can be handled using BSL-2 containment practices. Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See our titration result showing that the starting 2-fold diluted pseudovirus generates signal >100,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of a neutralizing antibody RV32 (Catalog # M17T52) with a negative control by using this pseudotyped virus. The results showed the neutralization titer for RV32 is 1 ng/ml. See figure